• Issue

    Hematological Oncology: Volume 32, Issue 3

    i, 113-168
    September 2014
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Issue Information

  • Page: i
  • First Published: 24 September 2014

Review

Programmed death 1 and B and T lymphocyte attenuator immunoreceptors and their association with malignant T-lymphoproliferative disorders: brief review

Stamatis Karakatsanis,  George Bertsias,  Paraskevi Roussou,  Dimitrios Boumpas, 
  • Pages: 113-119
  • First Published: 13 September 2013

Original Research Articles

The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas

Davide Soldini,  Antoin Georgis,  Chiara Montagna,  Peter Johannes Schüffler,  Vittoria Martin,  Alessandra Curioni-Fontecedro,  Antonio Martinez,  Marianne Tinguely, 
  • Pages: 120-125
  • First Published: 23 September 2013

Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT

Ruimin Wang,  Haiyan Zhu,  Yingmao Chen,  Can Li,  Fei Li,  Zhihui Shen,  Jiahe Tian,  Li Yu,  Baixuan Xu, 
  • Pages: 126-132
  • First Published: 01 September 2013

Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance

Irene Della Starza,  Marzia Cavalli,  Ilaria Del Giudice,  Daniela Barbero,  Barbara Mantoan,  Elisa Genuardi,  Marina Urbano,  Claudia Mannu,  Anna Gazzola,  Elena Ciabatti,  Anna Guarini,  Robin Foà,  Sara Galimberti,  Pierpaolo Piccaluga,  Gianluca Gaidano,  Marco Ladetto,  Luigia Monitillo, 
  • Pages: 133-138
  • First Published: 19 November 2013

Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone

David Aguiar-Bujanda,  Ignacio Llorca-Mártinez,  José C. Rivero-Vera,  María J. Blanco-Sánchez,  Pedro Jiménez-Gallego,  Marta Mori-De Santiago,  Miguel A. Limeres-Gonzalez,  José C. Cabrera-Marrero,  María Hernández-Sosa,  Saray Galván-Ruíz,  Samuel Hernández-Sarmiento,  Salvador Saura Grau,  Uriel Bohn-Sarmiento, 
  • Pages: 139-144
  • First Published: 09 October 2013

Aberrant immunoarchitecture distinguishes hyperplastic germinal centres in pattern 1 angioimmunoblastic T-cell lymphoma from reactive follicles

Leonard Hwan-Cheong Tan,  Soo-Yong Tan, 
  • Pages: 145-154
  • First Published: 19 November 2013

Letters to the Editor

MYC network mutations in high-risk chronic lymphocytic leukaemia

Sara Monti,  Clara Deambrogi,  Andrea Rinaldi,  Francesco Bertoni,  Gianluca Gaidano,  Davide Rossi, 
  • Pages: 155-157
  • First Published: 22 January 2014
Open Access

Molecular detection of BRAF-V600E is superior to flow cytometry for disease evaluation in hairy cell leukaemia

Tom Rider,  Robert Powell,  R. Gover,  Richard Ansell,  Sarah Bastow,  Rohit R. Ghurye,  Helen Stewart,  Timothy Chevassut, 
  • Pages: 158-161
  • First Published: 07 October 2013

Primary female genital system lymphoma: a single institution's experience over 10 years

Wen-Xiao Wei,  Jia-Jia Huang,  Yu Wang,  Yi Xia,  Xi-Wen Bi,  Wen-Qi Jiang,  Hui-Qiang Huang,  Tong-Yu Lin,  Zhi-Ming Li, 
  • Pages: 162-164
  • First Published: 08 January 2014

Electronic nose for tracking different types of leukaemia: future prospects in diagnosis

Ehab I. Mohamed,  Gihan N. Mahmoud,  Rania M. El-Sharkawy,  Ahmed M. Moro,  Samir M. Abdel-Mageed,  Metwally A. Kotb, 
  • Pages: 165-167
  • First Published: 12 September 2013

Erratum

Free Access

Erratum: No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia

  • Page: 168
  • First Published: 24 September 2014